Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Li-Fraumeni Syndrome × Specimen Handling × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 56 Lung Neoplasms 45 Leukemia, Myeloid, Acute 40 Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 35 Myelodysplastic Syndromes 26 Pancreatic Neoplasms 22 Multiple Myeloma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Colorectal Neoplasms 21 Carcinoma, Renal Cell 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Neoplasm Metastasis 18 Melanoma 18 Glioblastoma 18 Ovarian Neoplasms 17 Lymphoma, Large B-Cell, Diffuse 17 Brain Neoplasms 16 Triple Negative Breast Neoplasms 14 Carcinoma, Hepatocellular 12 Squamous Cell Carcinoma of Head and Neck 11 Leukemia, Myelomonocytic, Chronic 11 Fallopian Tube Neoplasms 11 Myeloproliferative Disorders 10 Lymphoma, Mantle-Cell 10 Lymphoma, Follicular 10 Lymphoma, B-Cell 10 Rectal Neoplasms 9 Glioma 9 Burkitt Lymphoma 9

Interventions

Specimen Handling 1 Physical Examination 1 Mastectomy, Subcutaneous 1 Mastectomy 1 Diffusion Magnetic Resonance Imaging 1 Colonoscopy 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04541654 2026-03-27

LiFT_UP

Dana-Farber Cancer Institute

Neoplastic Syndromes, Hereditary, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡